Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA009252-03
Application #
5209742
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Cornish, J W; Maany, I; Fudala, P J et al. (2001) A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug Alcohol Depend 61:183-9
Weinrieb, R M; Van Horn, D H; McLellan, A T et al. (2001) Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics 42:110-6
Ehrman, R N; Robbins, S J; Cornish, J W (2001) Results of a baseline urine test predict levels of cocaine use during treatment. Drug Alcohol Depend 62:1-7
Volpicelli, J R; Markman, I; Monterosso, J et al. (2000) Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy. J Subst Abuse Treat 18:41-9
Robbins, S J; Ehrman, R N; Childress, A R et al. (2000) Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug Alcohol Depend 59:33-42
Robbins, S J; Ehrman, R N; Childress, A R et al. (1999) Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend 53:223-30
Ehrman, R N; Robbins, S J; Childress, A R et al. (1998) Laboratory exposure to cocaine cues does not increase cocaine use by outpatient subjects. J Subst Abuse Treat 15:431-5
Ehrman, R N; Robbins, S J; Cornish, J W et al. (1996) Failure of ritanserin to block cocaine cue reactivity in humans. Drug Alcohol Depend 42:167-74